Scientists hunt for biomarkers to speed up CMT treatment trials
NCT ID NCT03386266
First seen May 10, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study involved 156 people with Charcot-Marie-Tooth disease type 1A (CMT1A), a rare nerve disorder. Researchers collected blood and skin samples over two years to find biological markers that could show how the disease progresses. The goal is to develop more sensitive tools for future clinical trials testing new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE, TYPE IA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Center Goettingen
Goettigen, Lower Saxony, 37075, Germany
Conditions
Explore the condition pages connected to this study.